ASHPOfficial

Front-line informatics pharmacists and health-system IT leaders share COVID-19 Emergency Use Authorization treatments and vaccines informatics pearls. Topics discussed will include standard IT and operational procedures for EUAs, EHR and infusion pump builds, compliance and documentation, and their tips on preparing for the next wave of EUAs.   

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this ASHP podcast, student members discuss ASHP’s Experiential Education program and dive into the ins and outs of an APPE rotation in association management. ASHP Pharmacy Student Forum Advisory Group members Rachael Crusius and Zach Krauss, engage with past ASHP externs about their virtual or in-person experiences and talk about how this rotation helped them to grow both professionally and personally in their pharmacy journey. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

 

 

The COVID-19 pandemic has caused changes in all practice settings of healthcare. The ambulatory setting has experienced some of the largest practice changes and advances. In this episode, we will explore how two ambulatory pharmacy leaders have navigated practice changes during this pandemic. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will describe important considerations for health systems of varying size regarding the handling and distribution process of the COVID-19 vaccine. The listeners of this podcast, organized by the Section of Pharmacy Practice Leaders Advisory Group on Strategy & Industry Disruptors, will hear from three different health systems on their lessons learned regarding the allocation of the COVID19 vaccine.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

 

 

In this podcast, Vicki Basalyga, ASHP Director of Clinical Specialists and Scientists, chats with team members from AMA and ASHP about the upcoming six-week summit and the combined efforts by both organizations to advance pharmacogenomics in the healthcare field.  

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Listen in as content matter experts share “pearls” of wisdom in this fast-paced, fun format.  This session features practitioners in Emergency Medicine and is brought to you by the Section of Clinical Specialists and Scientists Advisory Group on Emergency Medicine. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode will provide members a quick refresher on payer mandated alternative distribution models, commonly known as brown bagging and white bagging. We will review potential risks and benefits inherent to alternative distribution models and explain key factors motivating payers and manufacturers to adopt these methods. Finally, we will focus on certain situations where payer mandated policies can negatively affect patient care and what can be done to avoid such scenarios. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The ASHP Specialty Pharmacy State of Practice in Hospitals and Health Systems – Future Directions Summit will bring together key stakeholders to discuss how to advance health-system specialty pharmacy practice to optimize patient health outcomes. The interprofessional summit will feature focused discussions and recommendations on key areas in specialty pharmacy. Speakers will share an outline of the summit and the anticipated outcomes. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In today's episode, the NYCSHP share their story & lessons learned in their wellbeing and resilience journey. Our speakers discuss how they have engaged their peers and chapter members in the prevention of burnout and building resilience during the pandemic.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This Midyear Clinical Meeting session led by Erin Fox and Jeff Little teaches how the listener how to compare legislative and regulatory advocacy issues at the state and nation level and recommend appropriate advocacy strategies for current patient care issues. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.